-
Sacubitril/valsartan, sold
under the
brand name Entresto, is a fixed-dose
combination medication for use in
heart failure. It
consists of the neprilysin...
-
Sacubitril (/səˈkjuːbɪtrɪl/; INN) is an
antihypertensive drug used in
combination with valsartan. The
combination drug
sacubitril/valsartan,
known during...
- valsartan/amlodipine/hydrochlorothiazide, valsartan/nebivolol, and valsartan/
sacubitril.
Valsartan is used to
treat high
blood pressure,
heart failure, and to...
-
heart failure.
Sacubitril/valsartan (Entresto/LCZ696),
which has been
tested against enalapril in
patients with
heart failure.
Sacubitril (AHU-377), a prodrug...
- (secukinumab)
Psoriasis Diovan (valsartan)
Hypertension 4,417 2012 −22%
Entresto (
sacubitril/valsartan)
Heart failure Enterovioform (clioquinol)
Amoebiasis Eucreas/Galvus...
- (INN; or LBQ657) is the
active metabolite of the
antihypertensive drug
sacubitril,
which is used in the
treatment of
heart failure.
Solomon SD. "HFpEF in...
- (NEP). Recently, NEP
inhibitors have been developed, such as
Sacubitril and
Sacubitril/valsartan. They may be
clinically useful in
treating patients...
- or
Arnisee ARNI,
angiotensin receptor-neprilysin inhibitor: Valsartan/
sacubitril Arani (disambiguation) Arny (disambiguation) This
disambiguation page...
- vasodilation, angioedema, and
airway obstruction.
Gemopatrilat Cilazapril Sacubitril "International
Nonproprietary Names for
Pharmaceutical Substances (INN)...
-
heart failure. The
angiotensin receptor-neprilysin
inhibitors (ARNI)
sacubitril/valsartan is
recommended as
first choice of RAS
inhibitors in American...
